CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-20 | Louis Chrystal Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +420,000 | 420,000 | ||
| 2025-01-03 | Louis Chrystal Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2024-05-01 | Louis Chrystal Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +380,000 | 380,000 |
Page 1 of 1 · 3 trades